Search

everythinglearnresearchcommunity

for

Search:↓

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Uterine transplants for transgender women are feasible but need more research.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Germacrone in Curcuma aeruginosa extract degrades at high temperatures but is stable in certain solutions and unaffected by pH levels.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

A new treatment for hair loss shows promise with fewer side effects.

Testosterone may influence COVID-19 severity and outcomes.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

No cure for female pattern hair loss, but various effective treatments exist.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.